Cogent Biosciences

Oncology Therapeutics
Listed: NASDAQ: COGTSponsors visas
7Open roles1 posted in 30 days
64 daysTime to fillmedian of 11 closed rolesmarket: 31 days

Facts

as of Nov 16, 2026

Cogent Biosciences is a biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.

It is hiring: 7 open roles, 1 of them posted in the last 30 days.

Headquarters
Waltham, United States
Listing
NASDAQ: COGT
Open roles
7 in 2 citiesAlion job postings
Official records
Wikidata Q119857276
Website
cogentbio.com

As of Nov 16, 2026, Alion lists 7 open roles at Cogent Biosciences. Cogent Biosciences is headquartered in Waltham, United States.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Hiring slowly: few roles were posted lately.

Biotech is the largest family, 40 of open roles.

1Posted in 30 days14% of open roles are fresh
57%Remote roles4 of 7
2Hiring offices
Can they hire you from United States?by your location
Likely
13 open roles are in your country: you apply locally, no move needed.
United States13On site
Remote, from elsewhere4Rare
No posting offers visa sponsorship. Remote roles: 4.
Time to fillmedian days to close a role
Cogent Biosciences64 days
Market, same roles31 days
Alion signals0-100
Demand19
Pay5
Your chance48
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−100%
Sep 21This week
Open roles a week: 6 then, 0 now
Where the openings areshare of open roles · trend
Biotech40
Finance30▲
Legal20▼
Administrative10▲
Newest roles
Senior Manager, Medical Writing
≈ $117k – $205k per year (Estimated) · Equity · Hybrid · 6+ years exp · Bachelor's Degree · Waltham
Senior Clinical Trial Associate
≈ $110k – $194k per year (Estimated) · Equity · Hybrid · 3+ years exp · Bachelor's Degree · Waltham
Principal Scientist, Computational Chemistry
≈ $124k – $236k per year (Estimated) · Equity · In office · Full-Time · 3+ years exp · PhD · Boulder
Degree asked
Bachelor's Degree 80%Doctoral Degree (PhD) 20%
5 postings state a degree.
Benefits named in postingsshare of open roles
Parental leave7100%
Equity114%
Contract type
Full-Time 1
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family

Named in the work visa registers of United States.

United StatesUS 2 #4,273 of 8,998 sponsors
2H-1B filings in 12 months
1Green card filings
$113kMedian offered salary
Who they sponsor
Data scientists1
Project management specialists1
The salary offered for each occupationVisa pass · 90 credits

In the register as Cogent Biosciences Inc., Waltham, MA (+1 more)

Other sponsors in the same field
See 7 open roles Alert me
US Department of Labor · latest filing Apr 17, 2026

Footprint

Hiring in 2 cities in 1 country.

2Cities
1Countries
WalthamBusiest site
Loading the map
SiteTypeOpen rolesHires most forEngineering
Waltham United StatesHeadquarters5Finance, Biotech0%
Boulder United StatesRegional office2Administrative, Biotech0%
Source: office addresses in postings and company registers

Technologies named in job postings at Cogent Biosciences over the last 12 months, by layer, with the share of postings for each.

17Technologies in use
10Postings analysed
51/100Stack modernity
Sign in to see how your skills match this stackSign In
Full Cogent Biosciences tech stack17 technologies · by team · pay by technology · changes · similar stacks
Source: the technologies named in the company's postings and on its site

Milestones

Nov 2026
Went public NASDAQ: COGT
Oct 2026
Formerly PLEASE READ THIS AG (unumrx.com)
Each milestone is dated by its source: registers, filings, the press